Results 91 to 100 of about 874,981 (155)

Clinical practice guideline for psoriasis management in Latin America. [PDF]

An Bras Dermatol
Valenzuela F, Castro Ayarza JR, Kaplan D, Londoño-García AM, Macías García KDR, Magariños G, Rivas Záldivar ES, Franco M, Cano S, Cortés C, Cárdenas PJ, Castro C, Ferreira R, Martínez S, Ibatá Bernal L, Castillo JC, Ospina J.   +16 more
europepmc   +1 more source

The Immunological Intersection of Psoriasis and Autoimmune Diseases: Shared Pathways and Clinical Implications. [PDF]

Life (Basel)
Savu AP, Olteanu R, Ciuc DM, Tiron MA, Constantin TV, Mutu CC, Bucur Ș, Constantin MM.   +7 more
europepmc   +1 more source

Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Attenuate IMQ-Induced Psoriasiform Dermatitis: A Preclinical Experimental Study of Exosomal miR-125b-5p/STAT3 Signaling. [PDF]

Stem Cells Int
Li Z, Ren R, Wang Y, Fan Z, Zhang Y, Fu J, Huang J, Huang Y, Zhang K, Li Q.   +9 more
europepmc   +1 more source

How Organ Manifestations Beyond the Bone May Guide Risk Stratification and Treatment Decisions in Chronic Nonbacterial Osteomyelitis. [PDF]

Paediatr Drugs
Inguscio G, Schnabel A, Roberts E, Hedrich CM.   +3 more
europepmc   +1 more source

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway. [PDF]

Am J Cancer Res
Pan X, Wang Y, Luo J, Dai X, Zhang J, Zheng R, Xu H, Zhang Y, Zhang J, Wang Z, Cao T, Ma J.   +11 more
europepmc   +1 more source

The IL-23/-17 Axis in PsA: What Have We Learned in the Last 20 Years? [PDF]

Mediterr J Rheumatol
Theodoridou F, Katsouli O, Fragoulis GE.
europepmc   +1 more source

The Evaluation of the Clinical Effectiveness and Safety of Biologic Therapies in Psoriasis-Real-World Evidence up to 64 Weeks of Therapy. [PDF]

Med Sci (Basel)
Lemiesz P, Nowowiejska-Purpurowicz J, Kaminski TW, Flisiak I.   +3 more
europepmc   +1 more source

Multiple Modes of Action of Anti-TNF-α Antibodies for Inflammatory Bowel Diseases Beyond TNF-α Neutralization. [PDF]

Antibodies (Basel)
Watanabe T, Kudo M.
europepmc   +1 more source

Medical Therapies Beyond Infliximab for Perianal Fistulizing Crohn's Disease: Current Evidence and Future Perspectives. [PDF]

J Clin Med
Fuentes-Valenzuela E, Tarrasó FJ, Botella B, Nos P, Vera I, Iborra M.   +5 more
europepmc   +1 more source

Oral delivery of recombinant <i>Lactococcus lactis</i> expressing an IL-23 inhibitor as a potential therapeutic strategy for experimental colitis. [PDF]

Drug Deliv
Kopecna E, Raskova Kafkova L, Kosztyu P, Sloupenska K, Zachova K, Cutkova A, Skarda J, Vaculova J, Kuchar M, Panova N, Walimbwa S, Plavec TV, Berlec A, Maly P, Raska M.   +14 more
europepmc   +1 more source